New Device to Replace Aortic Valve in Patients Who Can't Have Open-Heart Surgery, University of California, Los Angeles (UCLA) Study
8/16/2012 7:51:16 AM
UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place on Aug. 9. Ronald Reagan UCLA Medical Center is part of a growing trend of hospitals nationwide offering this new minimally invasive procedure.